Dr. Ver Donck Ann

STUDIES

Medical Doctor in Internal Medicine, Surgery and Obstetrics at the Katholic University, Leuven Belgium, Cum Laude, 1987

Training in General Anaesthesa, Cardiac Anaesthesia, Reanimation, Intensive Care Medicine and Chronic Pain Management, under supervision and coördination of Professor Doctor H. Van Aken, Departement of Anaesthesia and Intesive Care medicine of the University Hospital, Leuven - Belgium, 1987 - 1992. One year of this training was performed at AZ Sint Lucas, Assebroek, Brugge, 1987-1988. Two years were performed at AZ Sint Jan, Brugge, 1990-1992.

Training in General Anaesthesia, Cardiac Anaesthesia and Intensive Care Medicine at the Bristol Royal Infirmary and Frenchay Hospital, Bristol, UK, 1 October 1989 - 31 September 1990

Qualification as a Specialist in Anaesthesia and Intensive Care Medicine by the Minister of Health and Environment, August 20 1992.

Qualification for the use of radioscopic and fluoroscopic imaging regarding radioprotection for ionising radiation, September 1998.

Accreditation since February 2002

1992 – 1997: Specialist in opleiding in Verloskunde, Gynaecologie en Infertiliteit, UZ Gent & St. Elisabeth Ziekenhuis Tilburg

1997: Diploma Gynaecologie en Verloskunde, Universiteit Gent

1999 – 2003: PhD aan Queen Mary University, Londen

2001 – 2004: Gynaecologisch Oncoloog, erkend door de Royal College of Obstetricians and Gynaecologists (MRCOG), Londen

POSTGRADUATE TRAINING

ICH GCP training course (Good Clinical Practice) for clinical research, 2010

Update cource in ICH GCP in january 2016

Previous Appointments (of greater than 6 months’ duration)

Dates: 1 july 1992 - 01 January 1996

Hospital: Ziekenhuisgroep Zeeuwsch-Vlaanderen (The Netherlands)

Position: Anaesthesiology and Chronic Pain Management

1

Membership of Societies:

The World Institute of Pain (WIP)

The International Neuromodulation Society (INS)

The IASP (International Association for the Study of pain)

The Local quality evaluation group (LOK pijn West en Oost Vlaanderen) nr. 1608, since January 28, 2002

Vlaamse Vereniging voor Anesthesiologische Pijnbestrijding (VAVP)

List of publications:

Poster presentation at 6th INS Congress, Madrid, Spain, 25-28/06/2003: Therapeutic dosage range of intrathecal ziconitide.

Chronic Pain management with the non opioid analgesic ziconotide, published in Highlights in Regional Anesthesia and Pain Therapy. XIII, 2004.

A Prospective, Open-label Study of Long-term Intrathecal Ziconotide for Chronic Nonmalignant Pain: A Case Report, submitted to Neuromodulation, October 2004.

Intrathecale medicatie toediening bij chronische pijnsyndromen, Hoofdstuk III – Speciële technieken. Gepubliceerd in het boek ‘Praktische Richtlijnen voor Anesthesiologische Pijnbestrijding’, pg 325-334, 2011

Intrathecal Drug Administration in Chronic Pain Syndromes, Pain Practice, 2013

Clinical Research Experience:

Patient controlled epidural analgesia for labour pain, a comparison with continuous infusion and bolus injections’, presented at the Belgian association for Anaesthesia and Reanimation. Gent February 22, 1992.

Effects and Adverse Events of Epidural Administration of Diprohos, completed 1999.

Multicenter, Phase II/III, Placebo Controlled Study of SNX-111 (Ziconitide) Administered Intrathecally to patients with Chronic Non-Malignant Pain: completed 2002.

Evolution of Endrocine Parameters during Intrathecal Administration of Opioids: completed 2002

Clinical registration of the use of Transdermal Buprenorfine, 2002

Registry on Retrograde Neurostimulation: start 2002, canceled 2003.

Synchromed PTM outcome study: completed 2004.

Evaluation of the safety and ease of use of the Synchromed II implantable infusion pump, started april 2003, completed july 2003.

Multicenter, 3 week, Open Label study of the effect and efficacy of Intrathecal
Administered Ziconitide (Prialt®), with an external pump, completed 2005.

Multicenter, Long-Term, Open Label study of the effect and efficacy of Intrathecal administered Ziconitide (Prialt®), completed 2007.

An open-label, long-term, multi-centre, multi-national observational study of the use of Prialt® (ziconotide intrathecal infusion) and alternative drugs for the management of severe, chronic pain. Started December 2008, completed 20-7-2012

"Octad Study: Evaluation of the Effectiveness of Octopolar Leads in Patients With Failed Back Surgery Syndrome With Chronic Low Back and/or Leg Pain During a One Year Follow-Up Period. A Prospective, Multicentre, Open-Label, Non-Randomized Study. ", completed March 2013-04-09

SubQStim, assessing the clinical and cost effectiveness of subcutaneous peripheral nerve stimulation, started December 2012, completed 21-01-2016

Presentations:

2

Patient controlled epidural analgesia for labour pain, a comparison with continuous infusion and bolus injections’, Belgian association for Anaesthesia and Reanimation. Gent February 22, 1992.

Symposium ’15 jaar pijnkliniek – Brugge: reflexie op het verleden, een blik naar de toekomst, actuele mogelijkheden in de pijnbestrijding.’ With international speakers known for their exprtise in chronic pain management. Organised by the Staff of the painclinic AZ Sint Jan, Brugge, with accreditation, Crowne Plaza Hotel, Brugge Belgium, February 5, 2000

Chronic Pain Management with the nonopioid Analgesic Ziconotide, presented at ‘Advances in the Management of the Chronic Pain Patient: a Hands-on cadaver Workshop for the Experienced User. Organised by ECMT – Brussels Belgium, June 25-26, 2004.

Curent Practice in Chronic Pain Management, Instructional Course for paramedics, KHBO, Brugge Belgium, twice a year since 2000.

‘Intrathecal drug delivery in patients with chronic severe pancreatitis’ & ‘SCS in Chronic Critical Limb ischemia’, presented at a satelitecongress Supported by an unrestricted grant from Medtronic during the World Congress on Pain, Sardinia, may 2001.

8832 Personal Therapy Manager – Clinical Experience, Synchromed II System Preview Event, Medtronic, Tolochenaz Switzerland, September 25-26, 2003

Chronic Pain Management with the nonopioid Analgesic Ziconotide, presented at ‘Advances in the Management of the Chronic Pain Patient: a Hands-on cadaver Workshop for the Experienced User. Organised by ECMT – Brussels Belgium, Januari 30-31, 2004.

Chronic Pain Management with the nonopioid Analgesic Ziconotide, presented at ‘Advances in the Management of the Chronic Pain Patient: a Hands-on cadaver Workshop for the Experienced User. Organised by ECMT (European Continous Medical Training – Brussels Belgium, June 25-26, 2004.

Chronic Pain Management with the nonopioid Analgesic Ziconotide, presented at the XXIII Annual ESRA Congress – Athens Greece, September 8-11, 2004.

Position of Buprenorphine patch on therapeutic Ladder: Questions and Answers. Manoir Stuyvenberg - Brugge, organised by Gruhnenthal, October 30 and November 27, 2003.

‘Introduction to Spinal Cord Stimulation’ and ‘Chronic Pain Patient Management’. Pain Patients Advocacy Group Meeting at the 3th World Congress - WIP (World Institute of Pain), Barcelona Spain, September 22, 2004

Ziconotide – A European treatment protocol. Presented at the Deutscher Schmerzkongress. Berlin, October 2005,

Ziconotide – A new approach to pain management. Meeting of the Spanish Pain Society Pain El Ferrol, Spain. October 2006

‘Ziconotide – A European treatment protocol’ presented at the Neuromodulation Society of Great Britain & Ireland (NSUKI) Annual Scientific Meeting. October 6th, 2006

Ziconotide – A new approach to pain management. Presented at the LOK meeting November 30, 2006

Evaluating Clinical Experience with Ziconotide ‘ presented at the 4th World Congress of the World Institute for Pain. Budapest, Hungary, September 26 – 2007.

3

‘Indications and practical aspects of the use of ziconotide’. Presented at ECMT (European Continous Medical Training) – Brussels Belgium, January 2008 18-19, 2008.

‘Drug Trials with Ziconotide – Fast, Slow, Bolus or No?’ Presented at The Intrathecal Drug Delivery Neuroscience Forum at Divonne-les-Bains, Switserland, December 12-13, 2008.

‘Type of Patient Suitable for Ziconotide Therapy and the part of the practical programme providing Practical Information on Ziconotide Use’. Prialt Network Launch, Barcelona, Spain. July 4-6, 2008

‘Treatment Possibilities of the Chronic Pain Patient’. Presented at the LOK meeting of Dermatologists. Brugge, 2 December 2008

‘Type of Patient Suitable for Ziconotide Therapy. Practical Information on Ziconotide Use’. Presented at the PRIALT UK Network Meeting, London, January 22, 2009.

‘Type of Patient Suitable for Ziconotide Therapy and the part of the practical programme providing Practical Information on Ziconotide Use’. Presented at the LOK meeting of Flemish Pain Therapists on February 19, 2009

Course on the practical aspects of the use of Prialt. Oporto, Portugal on the 16th of April 2009.

Organisation of a symposium to celebrate more than 20 year of experience in pain treatment at the Multidisciplinary Pain Centre in Brugge on ‘efficacy and evidence of neuromodulation techniques’, Brugge, 26 September 2009

‘Pathofysiology of Pain’ presented at the MPC Symposium, Brugge, 26-September 2009.

Prialt, a decade of experience. Presented at the 4th international symposium on interventional pain management: Invasive procedures in motion. Nottwil, 21 January 2011

Overzicht van de hedendaagse therapeutische mogelijkheden voor de chronische pijnpatiënt, KHBO postgraduate cursus ‘pijn’ voor pijnreferentieverpleegkundigen. Brugge, 29 april 2011 en oktober 2012.

Intrathecal Drug Delivery Workshop, organized by Medtronic at VUB. Lecture on Overview intrathecale pain treatment and hands-on instruction on implantation of a spinal catheter and trial procedure. Brussels, 7 june 2012.

Date: 12-8-2016
Signature: